(Q35859028)

10 August 2017

1 reference

title

Drug-gene interactions between genetic polymorphisms and antihypertensive therapy (English)

1 reference

10 August 2017

7

Bruce M Psaty

1 reference

10 August 2017

Cornelia M. van Duijn

6

object named as

Cornelia M Van Duijn

1 reference

10 August 2017

Hedi Schelleman

1

1 reference

10 August 2017

Bruno H Ch Stricker

2

1 reference

10 August 2017

Anthonius De Boer

3

1 reference

10 August 2017

Abraham A Kroon

4

1 reference

10 August 2017

Monique W M Verschuren

5

1 reference

10 August 2017

Olaf H Klungel

8

1 reference

10 August 2017

publication date

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

64

1 reference

10 August 2017

issue

16

1 reference

10 August 2017

page(s)

1801-1816

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200464160-00006

10 August 2017

exact match

0 references

cites work

Sample size determination for studies of gene-environment interaction

1 reference

12 December 2020

Response to a second single antihypertensive agent used as monotherapy for hypertension after failure of the initial drug. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

1 reference

12 December 2020

Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition.

1 reference

12 December 2020

Angiotensin I-converting enzyme genotypes and angiotensin II receptors. Response to therapy

1 reference

12 December 2020

Genomic medicine and the future of health care

1 reference

12 December 2020

The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects

1 reference

12 December 2020

Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Counterpoint: bias from population stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer.

1 reference

12 December 2020

Relationship between polymorphism in the angiotensinogen, angiotensin-converting enzyme or angiotensin II receptor and renal progression in Japanese NIDDM patients

1 reference

12 December 2020

Renin-angiotensin-aldosterone system and G-protein beta-3 subunit gene polymorphisms in salt-sensitive essential hypertension.

1 reference

12 December 2020

Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism

1 reference

12 December 2020

Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension

1 reference

12 December 2020

Pharmacogenomics of hypertension

1 reference

12 December 2020

Predicting response to chronic antihypertensive treatment with fosinopril: the role of angiotensin-converting enzyme gene polymorphism

1 reference

12 December 2020

Lack of association between Gly460Trp polymorphism of alpha-adducin gene and salt sensitivity of blood pressure in Polish hypertensives

1 reference

12 December 2020

The legacy of pharmacogenetics and potential applications.

1 reference

12 December 2020

Adducin polymorphism affects renal proximal tubule reabsorption in hypertension

1 reference

12 December 2020

Genetic structure of human populations

1 reference

12 December 2020

Angiotensin II sensitivity is associated with the angiotensin II type 1 receptor A(1166)C polymorphism in essential hypertensives on a high sodium diet

1 reference

12 December 2020

Hypertension: genes versus environment

1 reference

12 December 2020

Association between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisal.

1 reference

12 December 2020

The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial.

1 reference

12 December 2020

Excess stroke among hypertensive men and women attributable to undertreatment of hypertension

1 reference

12 December 2020

Association of angiotensin I-converting enzyme gene polymorphism with susceptibility to antiproteinuric effect of angiotensin I-converting enzyme inhibitors in patients with proteinuria

1 reference

12 December 2020

Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease

1 reference

12 December 2020

Genetic variation of the gamma subunit of the epithelial Na+ channel and essential hypertension. Relationship with salt sensitivity.

1 reference

12 December 2020

Segregation and linkage analysis of serum angiotensin I-converting enzyme levels: evidence for two quantitative-trait loci.

1 reference

12 December 2020

Interacting effects of gender and genotype on blood pressure response to hydrochlorothiazide

1 reference

12 December 2020

Antihypertensive pharmacogenetics: getting the right drug into the right patient

1 reference

12 December 2020

Gene polymorphism of the renin-angiotensin system associates with risk for lacunar infarction. The Ohasama study

1 reference

12 December 2020

B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial

1 reference

12 December 2020

Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II.

1 reference

12 December 2020

Aldosterone synthase (CYP11B2) -344 C/T polymorphism is related to antihypertensive response: result from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial

1 reference

12 December 2020

Angiotensin converting enzyme insertion/deletion polymorphism and short-term renal response to ACE inhibition: role of sodium status

1 reference

12 December 2020

Molecular basis of human hypertension: role of angiotensinogen

1 reference

12 December 2020

Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy

1 reference

12 December 2020

Alpha-adducin polymorphisms and renal sodium handling in essential hypertensive patients.

1 reference

12 December 2020

Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol

1 reference

12 December 2020

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

1 reference

12 December 2020

Relationship between the response to the angiotensin converting enzyme inhibitor imidapril and the angiotensin converting enzyme genotype

1 reference

12 December 2020

Linkage of the Angiotensinogen Gene to Essential Hypertension

1 reference

12 December 2020

Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies

1 reference

12 December 2020

Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients

1 reference

12 December 2020

Genetics of blood pressure, hypertensive complications, and antihypertensive drug responses

1 reference

12 December 2020

G-protein beta3 subunit 825T allele and response to dietary salt in normotensive men.

1 reference

12 December 2020

A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response

1 reference

12 December 2020

Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Aten

1 reference

12 December 2020

Control of blood pressure and risk of stroke among pharmacologically treated hypertensive patients

1 reference

12 December 2020

Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure

1 reference

12 December 2020

Pharmacogenetic interactions between beta-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure

1 reference

12 December 2020

Prediction of patient responses to antihypertensive drugs using genetic polymorphisms: investigation of renin-angiotensin system genes

1 reference

12 December 2020

The genetics of essential hypertension

1 reference

12 December 2020

Association of a human G-protein beta3 subunit variant with hypertension

1 reference

12 December 2020

A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro

1 reference

12 December 2020

The future of genetic studies of complex human diseases

1 reference

12 December 2020

Heterotrimeric G proteins: organizers of transmembrane signals

1 reference

12 December 2020

Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

1 reference

12 December 2020

The role of alpha-adducin polymorphism in blood pressure and sodium handling regulation may not be excluded by a negative association study

1 reference

12 December 2020

Renin-angiotensin system genetic polymorphisms and salt sensitivity in essential hypertension

1 reference

12 December 2020

Association of the G(s)alpha gene with essential hypertension and response to beta-blockade

1 reference

12 December 2020

Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension

1 reference

12 December 2020

Implications of cytochrome P450 interactions when prescribing medication for hypertension

1 reference

12 December 2020

Use of unlinked genetic markers to detect population stratification in association studies.

1 reference

12 December 2020

Pharmacogenetic analysis of the effect of angiotensin-converting enzyme inhibitor on restenosis after percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

Evaluation of the Angiotensinogen Locus in Human Essential Hypertension

1 reference

12 December 2020

Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis.

1 reference

12 December 2020

Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2

1 reference

12 December 2020

Pharmacokinetics of irbesartan are not altered in special populations

1 reference

12 December 2020

Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review

1 reference

12 December 2020

Concentration- or effect-controlled clinical trials with sparse data

1 reference

12 December 2020

The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition

1 reference

12 December 2020

Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors.

1 reference

12 December 2020

Effects of endothelial nitric oxide synthase, α-adducin, and other candidate gene polymorphisms on blood pressure response to hydrochlorothiazide

1 reference

12 December 2020

Point: population stratification: a problem for case-control studies of candidate-gene associations?

1 reference

12 December 2020

Pharmacogenomics of primary hypertension--the lessons from the past to look toward the future

1 reference

12 December 2020

Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels

1 reference

12 December 2020

Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction

1 reference

12 December 2020

Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol

1 reference

12 December 2020

Human hypertension caused by mutations in WNK kinases

1 reference

12 December 2020

Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport

1 reference

12 December 2020

Influence of the angiotensin II type 1 receptor gene polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals

1 reference

12 December 2020

ACE and α-Adducin Polymorphism as Markers of Individual Response to Diuretic Therapy

1 reference

12 December 2020

Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study

1 reference

12 December 2020

The detection of gene–environment interaction for continuous traits: should we deal with measurement error by bigger studies or better measurement?

1 reference

12 December 2020

Blood pressure level and incidence of myocardial infarction among patients treated for hypertension

1 reference

12 December 2020

Pathoaetiology, epidemiology and diagnosis of hypertension

1 reference

12 December 2020

Hypertension genetics, single nucleotide polymorphisms, and the common disease:common variant hypothesis

1 reference

12 December 2020

C825T polymorphism of the G protein beta(3)-subunit and antihypertensive response to a thiazide diuretic

1 reference

12 December 2020

Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension

1 reference

12 December 2020

Identification and characterization of G beta 3s2, a novel splice variant of the G-protein beta 3 subunit

1 reference

12 December 2020

Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension

1 reference

12 December 2020

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

1 reference

12 December 2020

Evidence for an interaction between adducin and Na(+)-K(+)-ATPase: relation to genetic hypertension

1 reference

12 December 2020

Therapeutic lessons from pharmacogenetics

1 reference

12 December 2020

Salt induces vascular AT1 receptor overexpression in vitro and in vivo

1 reference

12 December 2020

10.2165/00003495-200464160-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

10 August 2017

1015382142

0 references

1 reference